U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 205103
Company: GENUS LIFESCIENCES
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
YOSPRALA ASPIRIN; OMEPRAZOLE 81MG;40MG TABLET, DELAYED RELEASE;ORAL Discontinued None Yes No
YOSPRALA ASPIRIN; OMEPRAZOLE 325MG;40MG TABLET, DELAYED RELEASE;ORAL Discontinued None Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/14/2016 ORIG-1 Approval Type 4 - New Combination STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205103s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/205103Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/205103Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/18/2023 SUPPL-9 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205103s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/205103Orig1s009ltr.pdf
03/04/2022 SUPPL-8 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205103s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/205103Orig1s008ltr.pdf
04/28/2021 SUPPL-7 Labeling-Package Insert, Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205103Orig1s007ltr.pdf
11/27/2020 SUPPL-6 Labeling-Medication Guide, Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/205103Orig1s006ltr.pdf
06/07/2018 SUPPL-4 Labeling-Package Insert, Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/205103Orig1s004ltr.pdf
10/04/2017 SUPPL-1 Labeling-Medication Guide, Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205103Origs001ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
07/18/2023 SUPPL-9 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205103s009lbl.pdf
03/04/2022 SUPPL-8 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205103s008lbl.pdf
04/28/2021 SUPPL-7 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf
04/28/2021 SUPPL-7 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf
11/27/2020 SUPPL-6 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf
11/27/2020 SUPPL-6 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf
06/07/2018 SUPPL-4 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf
06/07/2018 SUPPL-4 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf
10/04/2017 SUPPL-1 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf
10/04/2017 SUPPL-1 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf
09/14/2016 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205103s000lbl.pdf
Back to Top